Fumie Tanzawa

Synthesis and Biological Evaluation of Benzothiazole Derivatives as Potent Antitumor Agents.

T. Agatsuma, H. Furukawa, N. Hayashi, 2005 .

Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents.

T. Agatsuma, H. Furukawa, N. Hayashi, 2005, Bioorganic & medicinal chemistry letters.

Antitumor activity and novel DNA‐self‐strand‐breaking mechanism of CNDAC (1‐(2‐C‐cyano‐2‐deoxy‐β‐d‐ARABINO‐Pentofuranosyl) cytosine) and its N4‐palmitoyl derivative (CS‐682)

A. Tomida, T. Tsuruo, Y. Wataya, 1999, International journal of cancer.

Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma

S. Tsutsumi, I. Kitabayashi, Ayuna Hattori, 2022, Journal of bone oncology.

Abstract 1132: Development and characterization of a novel orally bioavailable menin-MLL inhibitor for treatment of acute leukemia patients withMLL-rearrangement orNPM1mutation

N. Haginoya, Mayumi Kitagawa, S. Tsutsumi, 2021, Experimental and Molecular Therapeutics.

A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1.

Yutaka Ikeno, O. Ubukata, H. Hanzawa, 2018, Acta crystallographica. Section F, Structural biology communications.

Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17

Ayako Nakayama, M. Imoto, E. Tashiro, 2012, Anti-cancer drugs.